science
New Cholesterol Guidelines Recommend Earlier Screening and Testing for Adults
The American College of Cardiology and other medical organizations released new cholesterol guidelines last month. The recommendations advise adults to begin cholesterol checks at age 19 every five years and include testing for Lipoprotein(a). The guidelines emphasize lowering LDL cholesterol to reduce risks of heart disease and stroke.
Apr 9, 1:01 PM·1m read1 source
Substrate placeholder — needs reviewAudio version
Tap play to generate a narrated version.
The American College of Cardiology, along with other medical organizations, released new cholesterol management guidelines last month. These guidelines provide targets for cholesterol levels and suggest medications for certain patients. They aim to help patients and doctors address cardiovascular risks associated with cholesterol.
Cholesterol levels influence the risk of heart disease and stroke, with elevated levels increasing that risk over time. The guidelines recommend that adults start cholesterol screening at age 19, with checks at least every five years. For children, screening occurs once between ages 9 and 11 to detect inherited high cholesterol.
A lipid panel test, performed via blood draw at a primary care office, measures various cholesterol types. Doctors primarily focus on low-density lipoprotein (LDL) cholesterol, which can accumulate in artery walls. Lower LDL levels correlate with reduced risk of cardiovascular events such as heart attacks or strokes, according to evidence cited in the guidelines.
The guidelines also advise testing all adults for Lipoprotein(a), or Lp(a), at least once. Lp(a) is a genetically determined cholesterol type that elevates heart disease risk independently of other lipid levels. Adult Lp(a) levels are reached during childhood and remain stable throughout life, with limited exceptions.
Another test mentioned in the guidelines measures apolipoprotein B (ApoB), which counts total 'bad' cholesterol particles, including LDL, Lp(a), and very low-density lipoprotein (vLDL). Dr. T. Southwestern Medical Center in Dallas, stated that ApoB provides a reliable assessment of cholesterol-related risk.
This test is particularly useful for patients with metabolic conditions, such as diabetes or cardiovascular-kidney-metabolic syndrome, due to variations in LDL particle size and density. The guidelines encourage lowering slightly elevated cholesterol levels in some cases to mitigate long-term risks. Patients should consult primary care providers for personalized screening and management plans.
